InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,634.22
(
0.89%
)
US TECH 100
19,848.00
(
0.87%
)
Dow Jones
40,100.09
(
0.87%
)
Brent Oil
85.00
(
-0.13%
)
Bitcoin
58,065.97
(
1.25%
)
Post# of 649926
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

TheFinalCD

Send PM Follow Ignore
Followers 4055
Posts 151825
Boards Moderated 3
Alias Born 08/05/2009

TheFinalCD

Member Level

Re: Covid19freak post# 573001

Wednesday, 01/25/2023 5:59:51 AM

Wednesday, January 25, 2023 5:59:51 AM

Post# of 649926
https://finviz.com/quote.ashx?t=ARDS&ty=c&ta=1&p=d

Message in reply to:
(ARDS) $0.84 --BIG Phase 3 data in December ...Very low valuation of $17 million ,,positive results could push this stock toward $5


Closed enrollment in the Company’s Phase 3 study evaluating AR-301 for the treatment of Ventilator Associated Pneumonia (VAP). Aridis expects to report top-line data from this study in December 2022.

Always consult an Investment Professional, my posts are my own opinions, and not for investing decisions~!

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up